Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2005, Volume 12, Issue 01, pages 1-80

EDITORIAL
Br J Cardiol 2005;12:5-7

Towards sensible eating, how far do we have to go?

Every day we are bombarded with media headlines and news stories about obesity, physical inactivity, faddy diets and ‘miracle’ foods.But how far do we need...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:71-3

Developing an evaluated patient-mediated intervention for monitoring amiodarone therapy

Amiodarone is used to prevent atrial and ventricular arrhythmias in high-risk patients, such as after a myocardial infarction (MI) and in congestive cardiac failure. Its...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:65-70

Evidence-based treatment of hypertension: what’s the role of angiotensin II receptor blockers?

Many large studies have confirmed the importance of controlling hypertension in reducing cardiovascular morbidity and mortality. Prescribers are now faced with a wide choice of...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:61-3

Early amiodarone pulmonary toxicity simulating heart failure

We report a case of very early onset of amiodarone-induced pulmonary toxicity, which appeared 12 days after starting treatment. ...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:57-60

Antiplatelet therapy for stroke prevention

Antiplatelet therapy plays a major role in the secondary prevention of ischaemic stroke. The antiplatelet agents that are most used in the clinic include aspirin,...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:53-6

Holes and strokes

Five case histories are described to illustrate the importance of patent foramen ovale and atrial septal aneurysm as risk factors in stroke aetiology. Diagnostic methods,...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:47-9

Using the Framingham coronary risk appraisal functions to derive the expected annual number of UK coronary artery disease events

The Framingham Heart Study investigators have recently developed new coronary risk appraisal functions which relate risk factors to the short-term probability of experiencing cardiovascular disease...

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:37-44

Current insights and new opportunities for smoking cessation

Assisting smokers to stop smoking is often seen as a difficult task but is crucial for health improvement, especially for those with established cardiovascular disease....

Read More

CLINICAL ARTICLE
Br J Cardiol 2005;12:31-6

The role of candesartan in the treatment of chronic heart failure

The renin-angiotensin system (RAS) plays a fundamental role in cardiovascular pathophysiology. In particular, angiotensin II (AII) has been identified as a culprit in endothelial and...

Read More

EDITORIAL
Br J Cardiol 2005;12:9-10

ARBITER-2: judging the next step in lipid management

Statin therapy is established as the basis of lipid-lowering therapy in all patients with established atherosclerotic disease.1 However, statin trials show that 50–70% of cardiovascular...

Read More

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits